Inside the financial sector, the iShares U.S. Broker-Dealer & Securities Exchanges exchange-traded fund is stealing the ...

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 10, Goldman Sachs resumed coverage of the stock with a ‘Buy’ rating and a $19 ...

Rahul Jain, Head of India Equity Research & Asia Financials at Goldman Sachs, told NDTV Profit that FY27 will be 'very strong ...

Goldman Sachs is warning of a possible stock market correction, thanks to high risk-appetite and enthusiastic retail ...

Clients of BNY will be able to invest in money market funds whose ownership will be recorded on Goldman’s blockchain platform ...

The cuts had been pencilled in for September if there was any severe economic turmoil from President Trump’s tariff and trade ...

While Zudio continues to grow faster than the apparel market, the pace of market share gains will likely be slower than ...

Indian markets closed lower on Thursday, weighed down by disappointing IT earnings and cautious global sentiment, which ...

So, Nvidia and Nebius enjoy a close partnership. That's expected to be beneficial for the latter, since the AI chip giant is ...

Nebius stock rallies as Goldman Sachs issues a bullish note in its favor. Analyst Alex Duval expects NBIS shares to hit $68 ...